Iron deficiency—when there's too little iron in the blood—may affect a quarter of the world's population, and in particular, ...

Company remains on track to submit NDA for bitopertin in erythropoietic protoporphyria (EPP) in H2 2025Initiated APOLLO, a ...

Let's start with one of the most classic signs of iron deficiency, pallor, which just means that your skin or mucous ...

But while the successes are well known, investors should not ignore the very many unprofitable companies that simply burn through all their cash and collapse. So, the natural question for Disc ...

Current anticancer treatments essentially target the primary tumor cells that proliferate quickly, but do not effectively ...

His arms and legs were already paralyzed. Before the day was out, his breathing muscles gave out, he got blue in the face, and had to be put in an iron lung. Birdsall Sweet was never to escape ...

The case for Disc Medicine (NASDAQ:IRON) for investors looking for exposure to clinical-stage biotech, particularly in the underserved space of rare hematologic diseases, is an interesting one.

In this article, we are going to take a look at where Disc Medicine, Inc. (NASDAQ:IRON) stands against other best small-cap stocks to buy before they explode. Since the announcement of tariffs ...

In trading on Tuesday, shares of Disc Medicine Inc (Symbol: IRON) entered into oversold territory, hitting an RSI reading of 29.5, after changing hands as low as $47.015 per share. By comparison ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Travere Therapeutics (TVTX – Research ...